Phase I study of AZD1775 with radiation therapy (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM) and evaluation of intratumoral drug distribution (IDD) in patients with recurrent GBM Meeting Abstract
| Authors: | Alexander, B. M.; Ahluwalia, M. S.; Desai, A. S.; Dietrich, J.; Kaley, T. J.; Peereboom, D. M.; Takebe, N.; Supko, J. G.; Desideri, S.; Fisher, J. D.; Sims, M.; Ye, X.; Nabors, L. B.; Grossman, S. A.; Wen, P. Y. |
| Abstract Title: | Phase I study of AZD1775 with radiation therapy (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM) and evaluation of intratumoral drug distribution (IDD) in patients with recurrent GBM |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 87s |
| Language: | English |
| ACCESSION: | WOS:000411895703175 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.2005 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2005 -- Source: Wos |
